MATCH SIZE AND QUANTITY
Build your comparison.
Choose a labeled amount and selection to load matching prices.
Vial comparison
Compare Peptide 2 (T) listings by strength, selection and supplier. Inspect the original source behind each price.
MATCH SIZE AND QUANTITY
Choose a labeled amount and selection to load matching prices.
GO BEYOND THE PRICE
Select a strength and selection above to view price history, save a price watch or add it to your basket.
DOCUMENTATION PASSPORTS
Inspect the source report, recorded lot and document access. A report link does not confirm the batch currently shipping.
Loading documentation records…
Reported quantities in this family: 1, 10. Counts and units must be matched to the exact listing.
Choose the labeled amount per unit and quantity before comparing. A single unit and a multipack have different upfront prices. Keep product format and exact recipe consistent; similar names do not establish equivalent products.
Follow the original listing to check its quantity, availability and current price. Unit prices use the full labeled mass in each selection.
Compare within each strength. Every row covers one vial and includes only listings marked in stock with known quantities.
| Strength | Selection | Lowest listed total price | Price per mg | Supplier count | Compare |
|---|---|---|---|---|---|
| 10 mg | 1 vial | $89.00 | $8.90 | 1 | Compare |
| 30 mg | 1 vial | $149.00 | $4.97 | 1 | Compare |
| 60 mg | 1 vial | $239.00 | $3.98 | 1 | Compare |
| 120 mg | 1 vial | $299.00 | $2.49 | 1 | Compare |
| 150 mg | 1 vial | $329.00 | $2.19 | 1 | Compare |

122 products · 249 listings
10 listings from direct supplier captures. Capture and import dates record when data was obtained; they do not guarantee the supplier’s current price or stock.
Listings include out-of-stock and unconfirmed-stock records. Inclusion does not certify a supplier, a batch or a product. Read how matching and source dates work.
FROM PEPTIDES CALCULATOR
Source profile reviewed 2026-10-01 · Imported 2026-10-22. Read the full compound profile
Tirzepatide (LY3298176) is a once-weekly injectable peptide that activates both the GIP and GLP-1 receptors, a 39-amino-acid analog with a C20 fatty diacid side chain that binds albumin and gives it a half-life of 5 to 6 days. The FDA approved it in 2022 as Mounjaro for type 2 diabetes, then as Zepbound for chronic weight management and for moderate to severe obstructive sleep apnea in adults with obesity; the 2026 Mounjaro label also covers children from age 10. In the phase 3 program it lowered HbA1c by about 2 percentage points and beat semaglutide 1 mg in SURPASS-2, produced 20.9% mean weight loss at 72 weeks on 15 mg in SURMOUNT-1, and out-performed semaglutide 2.4 mg head to head in SURMOUNT-5. Both labels carry a boxed warning for thyroid C-cell tumors seen in rodents, and compounded or grey-market vials sold at concentrations from 5 to 20 mg/mL account for most of the dosing confusion documented online.
A 72-week randomized trial compared weekly 5, 10, and 15 mg doses with placebo in 2,539 adults without diabetes.
A prespecified population with obesity and prediabetes was followed through 176 weeks of treatment.
The 2.5 mg initiation step is followed by 2.5 mg increments when clinically appropriate.
Background is reproduced from Peptides Calculator with attribution. The source describes compound-level research. It does not evaluate the identity, quality or suitability of a listed supplier’s product or batch.